Investors with a lot of money to spend have taken a bullish stance on Recursion Pharmaceuticals RXRX.
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with RXRX, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 8 uncommon options trades for Recursion Pharmaceuticals.
This isn't normal.
The overall sentiment of these big-money traders is split between 62% bullish and 37%, bearish.
Out of all of the special options we uncovered, 6 are puts, for a total amount of $481,336, and 2 are calls, for a total amount of $174,117.
Expected Price Movements
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $7.0 and $12.0 for Recursion Pharmaceuticals, spanning the last three months.
Insights into Volume & Open Interest
In terms of liquidity and interest, the mean open interest for Recursion Pharmaceuticals options trades today is 1178.5 with a total volume of 1,002.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Recursion Pharmaceuticals's big money trades within a strike price range of $7.0 to $12.0 over the last 30 days.
Recursion Pharmaceuticals 30-Day Option Volume & Interest Snapshot
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RXRX | PUT | SWEEP | BEARISH | 09/20/24 | $4.0 | $3.8 | $4.0 | $12.00 | $240.0K | 2.5K | 2 |
| RXRX | CALL | SWEEP | BEARISH | 09/20/24 | $1.8 | $1.5 | $1.8 | $7.00 | $140.1K | 955 | 422 |
| RXRX | PUT | TRADE | BULLISH | 09/20/24 | $5.0 | $3.9 | $4.0 | $12.00 | $80.0K | 2.5K | 2 |
| RXRX | PUT | SWEEP | BULLISH | 12/20/24 | $4.0 | $3.8 | $3.8 | $11.00 | $57.0K | 556 | 277 |
| RXRX | PUT | SWEEP | BULLISH | 12/20/24 | $1.8 | $1.65 | $1.65 | $8.00 | $49.1K | 700 | 2 |
About Recursion Pharmaceuticals
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Present Market Standing of Recursion Pharmaceuticals
- Currently trading with a volume of 1,728,488, the RXRX's price is up by 0.36%, now at $8.38.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 19 days.
What The Experts Say On Recursion Pharmaceuticals
In the last month, 2 experts released ratings on this stock with an average target price of $14.5.
- Consistent in their evaluation, an analyst from Keybanc keeps a Overweight rating on Recursion Pharmaceuticals with a target price of $12.
- Reflecting concerns, an analyst from Needham lowers its rating to Buy with a new price target of $17.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Recursion Pharmaceuticals options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
